Published

A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: The international journal of neuropsychopharmacology
Date: 2021-09-21
Source: PubMed
DOI: 10.1093/ijnp/pyab040
PubMed: 34228806

Authors

Hagsäter SM Pettersson R Pettersson C Atanasovski D Näslund J Eriksson E

Watch author

Derived topics and classifications

psilocybin Anxiety Receptor Pharmacology Other

Citation graph

0 referenced DOIs found in stored source metadata. 4 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex2026-06-28 Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in rats2026-06-01 Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models2023-09-01 A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear.2021-09-21

Related papers

Investigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive DisorderClinicalTrials.gov · 2025-05-14 PRISMatic: A Phase 1b Randomized, Double-Armed, Parallel-Group, Placebo-Controlled Trial of Psilocybin Efficacy With or Without Pimavanserin PretreatmentClinicalTrials.gov · 2026-07-21 The Efficacy of Psilocybin Therapy for Depression in Parkinson's DiseaseClinicalTrials.gov · 2026-08-07